IBDEI2V1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45628,1,3,0)
 ;;=3^Polymyositis
 ;;^UTILITY(U,$J,358.3,45628,1,4,0)
 ;;=4^M33.20
 ;;^UTILITY(U,$J,358.3,45628,2)
 ;;=^5011770
 ;;^UTILITY(U,$J,358.3,45629,0)
 ;;=R80.9^^172^2273^45
 ;;^UTILITY(U,$J,358.3,45629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45629,1,3,0)
 ;;=3^Proteinuria
 ;;^UTILITY(U,$J,358.3,45629,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,45629,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,45630,0)
 ;;=R76.11^^172^2273^41
 ;;^UTILITY(U,$J,358.3,45630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45630,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,45630,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,45630,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,45631,0)
 ;;=M35.00^^172^2273^49
 ;;^UTILITY(U,$J,358.3,45631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45631,1,3,0)
 ;;=3^Sjogren Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,45631,1,4,0)
 ;;=4^M35.00
 ;;^UTILITY(U,$J,358.3,45631,2)
 ;;=^5011786
 ;;^UTILITY(U,$J,358.3,45632,0)
 ;;=B37.0^^172^2273^55
 ;;^UTILITY(U,$J,358.3,45632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45632,1,3,0)
 ;;=3^Thrush
 ;;^UTILITY(U,$J,358.3,45632,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,45632,2)
 ;;=Thrush^5000612
 ;;^UTILITY(U,$J,358.3,45633,0)
 ;;=I83.91^^172^2274^12
 ;;^UTILITY(U,$J,358.3,45633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45633,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,45633,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,45633,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,45634,0)
 ;;=I83.92^^172^2274^11
 ;;^UTILITY(U,$J,358.3,45634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45634,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,45634,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,45634,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,45635,0)
 ;;=I83.93^^172^2274^10
 ;;^UTILITY(U,$J,358.3,45635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45635,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
 ;;^UTILITY(U,$J,358.3,45635,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,45635,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,45636,0)
 ;;=I83.019^^172^2274^9
 ;;^UTILITY(U,$J,358.3,45636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45636,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,45636,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,45636,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,45637,0)
 ;;=I83.029^^172^2274^8
 ;;^UTILITY(U,$J,358.3,45637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45637,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,45637,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,45637,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,45638,0)
 ;;=I71.4^^172^2274^1
 ;;^UTILITY(U,$J,358.3,45638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45638,1,3,0)
 ;;=3^AAA w/o rupture
 ;;^UTILITY(U,$J,358.3,45638,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,45638,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,45639,0)
 ;;=I73.9^^172^2274^3
 ;;^UTILITY(U,$J,358.3,45639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45639,1,3,0)
 ;;=3^PVD, unspec
 ;;^UTILITY(U,$J,358.3,45639,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,45639,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,45640,0)
 ;;=I80.201^^172^2274^4
 ;;^UTILITY(U,$J,358.3,45640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45640,1,3,0)
 ;;=3^Phlebitis & thrombophlebitis deep vessels, right lower extremity
